Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa.

Yegorov S, Joag V, Galiwango RM, Good SV, Okech B, Kaul R.

Trop Dis Travel Med Vaccines. 2019 Nov 29;5:22. doi: 10.1186/s40794-019-0097-5. eCollection 2019. Review.

2.

Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men.

Galiwango RM, Bagaya B, Mpendo J, Joag V, Okech B, Nanvubya A, Ssetaala A, Muwanga M, Kaul R.

Trials. 2019 Jul 19;20(1):443. doi: 10.1186/s13063-019-3545-7.

3.

Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways.

Yegorov S, Joag V, Galiwango RM, Good SV, Mpendo J, Tannich E, Boggild AK, Kiwanuka N, Bagaya BS, Kaul R.

Nat Commun. 2019 May 24;10(1):2296. doi: 10.1038/s41467-019-09900-9.

4.

Characterization of CD4+ T cell subsets and HIV susceptibility in the inner and outer foreskin of Ugandan men.

Galiwango RM, Yegorov S, Joag V, Prodger J, Shahabi K, Huibner S, Muyanja E, Kabuubi BR, Namuniina A, Nalutaaya A, Ssemaganda A, Lutwama F, Kitandwe PK, Nanvubya A, Mpendo J, Bagaya B, Kiwanuka N, Kaul R.

Am J Reprod Immunol. 2019 Jul;82(1):e13143. doi: 10.1111/aji.13143. Epub 2019 May 24.

PMID:
31081958
5.

Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.

Yegorov S, Galiwango RM, Good SV, Mpendo J, Tannich E, Boggild AK, Kiwanuka N, Bagaya BS, Kaul R.

BMC Infect Dis. 2018 Nov 19;18(1):586. doi: 10.1186/s12879-018-3481-2.

6.

HIV Prevention Efforts and Incidence of HIV in Uganda.

Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, Kigozi G, Kagaayi J, Ssekubugu R, Nalugoda F, Lessler J, Lutalo T, Galiwango RM, Makumbi F, Kong X, Kabatesi D, Alamo ST, Wiersma S, Sewankambo NK, Tobian AAR, Laeyendecker O, Quinn TC, Reynolds SJ, Wawer MJ, Chang LW; Rakai Health Sciences Program.

N Engl J Med. 2017 Nov 30;377(22):2154-2166. doi: 10.1056/NEJMoa1702150.

7.

Low prevalence of laboratory-confirmed malaria in clinically diagnosed adult women from the Wakiso district of Uganda.

Yegorov S, Galiwango RM, Ssemaganda A, Muwanga M, Wesonga I, Miiro G, Drajole DA, Kain KC, Kiwanuka N, Bagaya BS, Kaul R.

Malar J. 2016 Nov 14;15(1):555.

8.

Genital Anaerobic Bacterial Overgrowth and the PrePex Male Circumcision Device, Rakai, Uganda.

Liu CM, Prodger JL, Tobian AA, Serwadda D, Galiwango RM, Nalugoda F, Kighoma N, Mwinike J, Anyokorit M, Price LB, Wawer MJ, Kigozi G, Gray RH.

J Infect Dis. 2016 Aug 15;214(4):595-8. doi: 10.1093/infdis/jiw182. Epub 2016 May 13.

9.

Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda.

Liu CM, Hungate BA, Tobian AA, Ravel J, Prodger JL, Serwadda D, Kigozi G, Galiwango RM, Nalugoda F, Keim P, Wawer MJ, Price LB, Gray RH.

mBio. 2015 Jun 16;6(3):e00589. doi: 10.1128/mBio.00589-15.

10.

Effects of medical male circumcision (MC) on plasma HIV viral load in HIV+ HAART naïve men; Rakai, Uganda.

Kigozi G, Musoke R, Kighoma N, Watya S, Serwadda D, Nalugoda F, Kiwanuka N, Wabwire-Mangen F, Tobian A, Makumbi F, Galiwango RM, Sewankambo N, Nkale J, Nalwoga GK, Anyokorit M, Lutalo T, Gray RH, Wawer MJ.

PLoS One. 2014 Nov 21;9(11):e110382. doi: 10.1371/journal.pone.0110382. eCollection 2014.

11.

Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.

Galiwango RM, Lubyayi L, Musoke R, Kalibbala S, Buwembo M, Kasule J, Serwadda D, Gray RH, Reynolds SJ, Chang LW.

PLoS One. 2014 Mar 10;9(3):e88928. doi: 10.1371/journal.pone.0088928. eCollection 2014.

12.

Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria.

Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, Contente-Cuomo TL, Wawer MJ, Keim P, Gray RH, Price LB.

mBio. 2013 Apr 16;4(2):e00076. doi: 10.1128/mBio.00076-13.

13.

Evaluation of current rapid HIV test algorithms in Rakai, Uganda.

Galiwango RM, Musoke R, Lubyayi L, Ssekubugu R, Kalibbala S, Ssekweyama V, Mirembe V, Nakigozi G, Reynolds SJ, Serwadda D, Gray RH, Kigozi G.

J Virol Methods. 2013 Sep;192(1-2):25-7. doi: 10.1016/j.jviromet.2013.04.003. Epub 2013 Apr 11.

14.

A Quality Management Approach to Implementing Point-of-Care Technologies for HIV Diagnosis and Monitoring in Sub-Saharan Africa.

Shott JP, Galiwango RM, Reynolds SJ.

J Trop Med. 2012;2012:651927. doi: 10.1155/2012/651927. Epub 2012 Jan 11.

15.

HIV type 1 genetic variation in foreskin and blood from subjects in Rakai, Uganda.

Galiwango RM, Lamers SL, Redd AD, Manucci J, Tobian AA, Sewankambo N, Kigozi G, Nakigozi G, Serwadda D, Boaz I, Nalugoda F, Sullivan DJ, Kong X, Wawer MJ, Gray RH, Quinn TC, Laeyendecker O; Rakai Health Sciences Program.

AIDS Res Hum Retroviruses. 2012 Jul;28(7):729-33. doi: 10.1089/AID.2011.0176. Epub 2011 Sep 19.

16.

Utility of a point-of-care malaria rapid diagnostic test for excluding malaria as the cause of fever among HIV-positive adults in rural Rakai, Uganda.

Mills LA, Kagaayi J, Nakigozi G, Galiwango RM, Ouma J, Shott JP, Ssempijja V, Gray RH, Wawer MJ, Serwadda D, Quinn TC, Reynolds SJ.

Am J Trop Med Hyg. 2010 Jan;82(1):145-7. doi: 10.4269/ajtmh.2010.09-0408.

Supplemental Content

Loading ...
Support Center